Delcath Systems Inc (DCTH) is a publicly traded Healthcare sector company. As of October 19, 2026, DCTH trades at $14.85 with a market cap of $488.56M and a P/E ratio of 1550.50. DCTH moved +2.06% today. Year to date, DCTH is +44.42%; over the trailing twelve months it is +20.05%. Its 52-week range spans $8.12 to $18.23. Analyst consensus is strong buy with an average price target of $24.50. Rallies surfaces DCTH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for DCTH, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $14.85 |
| Market Cap | $488.56M |
| P/E Ratio | 1550.50 |
| EPS | $0.01 |
| Dividend Yield | 0.00% |
| 52-Week High | $18.23 |
| 52-Week Low | $8.12 |
| Volume | 241.21K |
| Avg Volume | 0 |
| Revenue (TTM) | $95.42M |
| Net Income | $532.00K |
| Gross Margin | 87.05% |
4 analysts cover DCTH: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $24.50.